期刊文献+

华法林相关性脑出血 被引量:1

Warfarin-associated intracerebral hemorrbage
原文传递
导出
摘要 华法林相关性脑出血发病率逐渐升高,早期病死率高达50%。危险因素包括高龄、国际标准化比率〉3.5、高血压、卒中史、白质疏松、淀粉样脑血管病、伴随抗血小板治疗等。预后较差,尚无最佳治疗。 The incidence of warfarin-associated intracerebral hemorrhage is increasing gradually. Its early mortality is as high as 50%. The risk factors include advanced age, international normalized ratio 〉 3.5, hypertension, previous stroke, leukoaralosis, cerebral amyloid angiopathy, and concomitant antiplatelet therapy, etc. Its prognosis was poor and there is no optimal treatment.
出处 《国际脑血管病杂志》 北大核心 2010年第6期417-422,共6页 International Journal of Cerebrovascular Diseases
基金 沈阳军区总医院院课题(05Y-B06)
关键词 脑出血 华法林 抗凝药 凝血因子类 因子Ⅶa 维生素K Cerebral hemorrhage Warfarin Anticoagulants Blood coagulation factors Factor Ⅶa Vitamin K
  • 相关文献

参考文献37

  • 1Flaherty ML,Kissela B,Woo D,et al.The increasing incidence of anticoagulant-associated intracerebral hemorrhage.Neurology,2007,68:116-121.
  • 2Aiyagari V,Testai FD.Correction of coagulopathy in warfarin associated cerebral hemorrhage.Curr Opin Grit Care,2009,15:87-92.
  • 3Hylek EM.Complications of oral anticoagulant therapy:bleeding and nonbleeding,rates and risk factors.Semin Vase Med,2003,3:271-278.
  • 4Aguilar MI,Hart RG,Kase CS,et al.Treatment of warfarin-associated intracerebral hemorrhage:literature review and expert opinion.Mayo Clin Proc,2007,82:82-92.
  • 5Freeman WD,Aguilar MI.Management of warfarin-related intracerebral hemorrhage.Expert Rev Neurother,2008,8:271 -290.
  • 6Hart RG,Tonarelli SB,Pearce LA Avoiding central nervous system bleeding during antithrombotic therapy:recent data and ideas.Stroke,2005,36:1588-1593.
  • 7Jeffree RL,Gordon DH,Sivasubramaniarn R,et al.Warfarin related intracranial haemorrhage:a case-controlled study of anticoagulation monitoring prior to spontaneous subdural or intracerebral haemorrhage.J Clin Neurosci,2009,16:882-885.
  • 8Toyoda K,Yasaka M,Iwade K,et al; Bleeding with Antithrombotic Therapy (BAT) Study Group.Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease:a prospective,multicenter,observational study.Stroke,2008,39:1740-1745.
  • 9Flaherty ML,Adeoye O,Sekar P,et al.The challenge of designing a treatment trial for warfarin-associated intracerebral hemorrhage.Stroke,2009,40:1738-1742.
  • 10Petty GW,Brown RD Jr,Whisnant JP,et al.Frequency of major complications of aspirin,warfarin,and intravenous heparin for secondary stroke prevention.A population-based study.Ann Intern Med,1999,130:14-22.

同被引文献31

  • 1van Asch C J, Luitse M J, Rinkel GJ, et al. Incidence, case fatality,and fttnctional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol, 2010, 9: 167-176.
  • 2Steiner T, Petersson J, A1-Shahi Salman R, et al; European Research Network on Intracerebral Haemorrhage. European research priorities for intracerebral haemorrhage. Cerebrovasc Dis, 2011, 32: 409-419.
  • 3Yang QD, Niu Q, Zhou YH, et al. Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000. Cerebrovasc Dis, 2004, 17: 303-313.
  • 4Zhang LF, Yang J, Hong Z, et al; Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology. Proportion of different subtypes of stroke in China. Stroke, 2003, 34: 2091-2096.
  • 5Wang WJ, Lu JJ, Wang YJ, et al; China National Stroke Registry (CNSR). Clinical characteristics, rmnagement, and functional outcomes in Chinese patients within the first year after intmcerebral hemorrhage: analysis from China National Stroke Registry. CNS Neurosci Ther, 2012, 18: 773-780.
  • 6Ojemarm RG, Heros RC. Spontaneous brain hemorrhage. Stroke, 1983, 14: 468-475.
  • 7Grieve JP. Spontaneous intracranial haemorrhage. Surgery (Oxf), 2009, 27: 120-124.
  • 8Manno EM. Update on intracerebral hemorrhage. Continuum (Minneap Minn), 2012, 18: 598-610.
  • 9Kim YZ, Park YH, Song YG, et al. Clinical analysis of factors predisposing the recurrence of primary intracerebral hemorrhage in patients taking anti-hypertensive drugs: A prospective cohort study. Clin Neurol Netwosurg. 2013, 115: 578-586.
  • 10Lee TH. Blood pressure control is important for primary and secondary prevention of intracranial hemorrhage in Taiwan. Acta Neurol Taiwan, 2007, 16: 66-67.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部